Anixa Biosciences, Inc. (ANIX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.74M | -2.61M | -1.25M | -1.51M | -1.5M | -2.9M | -927K | -2.64M | -2.64M | -2.31M | -1.97M | -1.45M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -15.83% | 10.12% | -35.38% | 42.83% | 43.13% | -25.77% | 52.92% | -82.91% | -227.51% | -16.15% | -23.6% | -3.51% |
| Net Income | -2.54M | -2.58M | -2.69M | -2.28M | -2.81M | -3.21M | -2.91M | -3.31M | -3.31M | -3.29M | -2.72M | -2.55M |
| Depreciation & Amortization | 0 | 57K | 9K | 9K | 9K | 9K | 9K | 3K | 3K | 13K | 12K | 11K |
| Stock-Based Compensation | 665K | 768K | 0 | 829K | 962K | 1.03M | 980K | 1.09M | 1.09M | 1.11M | 1.16M | 1.15M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -20K | 28K | 834K | 13K | 199K | -228K | 24K | 182K | 182K | 152K | 71K | 64K |
| Working Capital Changes | 150K | -878K | 597K | -82K | 140K | -503K | 973K | -607K | -607K | -292K | -488K | -125K |
| Change in Receivables | -56K | 0 | 0 | 0 | 0 | 173K | 237K | -192K | -192K | -121K | 64K | -79K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 104K | -17K | -111K | -8K | -316K | 75K | 223K | 87K | 87K | 158K | 112K | -102K |
| Cash from Investing | 422K | 1.23M | 654K | -833K | 2.34M | 2.7M | 867K | 2.72M | 2.72M | 129K | -593K | -980K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -24.64M | 0 | -20.66M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 1.25M | 1.69M | 350K | 1.93M | 18K | -17K | 106K | 149K | 149K | 2.26M | 279K | 3K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 4K | 60K | 350K | 1.93M | 14K | -17K | -35K | -45K | -45K | 2.2M | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 3K | 14K | -17K | -6K | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 1.25M | 1.63M | 0 | 2K | 4K | 0 | 141K | 194K | 194K | 67K | 279K | 3K |
| Net Change in Cash | -70K | 303K | -251K | -415K | 857K | -218K | 46K | 230K | 230K | 83K | -2.28M | -2.42M |
| Free Cash Flow | -1.74M | -2.61M | -1.25M | -1.51M | -1.5M | -2.9M | -927K | -2.64M | -2.64M | -2.31M | -1.97M | -1.45M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -15.83% | 10.12% | -35.38% | 42.83% | 43.13% | -25.77% | 52.92% | -82.91% | -227.51% | -16.15% | -23.6% | -3.51% |
| FCF per Share | -0.05 | -0.08 | -0.04 | -0.05 | -0.05 | -0.09 | -0.03 | -0.08 | -0.08 | -0.07 | -0.06 | -0.05 |
| FCF Conversion (FCF/Net Income) | 0.68x | 1.02x | 0.47x | 0.67x | 0.54x | 0.91x | 0.32x | 0.81x | 0.81x | 0.71x | 0.73x | 0.58x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |